Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1980 2
1982 1
1983 2
1984 3
1985 1
1986 3
1987 1
1989 7
1990 6
1991 6
1992 1
1993 6
1994 8
1995 1
1996 2
1997 5
1998 6
1999 4
2000 8
2001 9
2002 2
2003 8
2004 3
2005 7
2006 5
2007 6
2008 8
2009 4
2010 4
2011 7
2012 17
2013 15
2014 18
2015 18
2016 11
2017 17
2018 13
2019 13
2020 22
2021 26
2022 23
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for M. hashizume
Search for M. Hashidume instead (3 results)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Preserved Trial Investigators. Anker SD, et al. N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27. N Engl J Med. 2021. PMID: 34449189 Clinical Trial.
Translating IL-6 biology into effective treatments.
Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Choy EH, et al. Nat Rev Rheumatol. 2020 Jun;16(6):335-345. doi: 10.1038/s41584-020-0419-z. Epub 2020 Apr 23. Nat Rev Rheumatol. 2020. PMID: 32327746 Free PMC article. Review.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F; EMPEROR-Reduced Trial Investigators. Packer M, et al. N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28. N Engl J Med. 2020. PMID: 32865377 Clinical Trial.
The annual rate of decline in the estimated glomerular filtration rate was slower in the empagliflozin group than in the placebo group (-0.55 vs. -2.28 ml per minute per 1.73 m(2) of body-surface area per year, P<0.001), and empagliflozin-treated patients had a lower ri …
The annual rate of decline in the estimated glomerular filtration rate was slower in the empagliflozin group than in the placebo group (-0.5 …
Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries.
Alahmad B, Khraishah H, Royé D, Vicedo-Cabrera AM, Guo Y, Papatheodorou SI, Achilleos S, Acquaotta F, Armstrong B, Bell ML, Pan SC, de Sousa Zanotti Stagliorio Coelho M, Colistro V, Dang TN, Van Dung D, De' Donato FK, Entezari A, Guo YL, Hashizume M, Honda Y, Indermitte E, Íñiguez C, Jaakkola JJK, Kim H, Lavigne E, Lee W, Li S, Madureira J, Mayvaneh F, Orru H, Overcenco A, Ragettli MS, Ryti NRI, Saldiva PHN, Scovronick N, Seposo X, Sera F, Silva SP, Stafoggia M, Tobias A, Garshick E, Bernstein AS, Zanobetti A, Schwartz J, Gasparrini A, Koutrakis P. Alahmad B, et al. Circulation. 2023 Jan 3;147(1):35-46. doi: 10.1161/CIRCULATIONAHA.122.061832. Epub 2022 Dec 12. Circulation. 2023. PMID: 36503273 Free PMC article.
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation.
Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, Eshima K, Tanizawa K, Fukuzawa M, Hayashi T, Akishita M, Lip GYH, Yamashita T; ELDERCARE-AF Committees and Investigators. Okumura K, et al. N Engl J Med. 2020 Oct 29;383(18):1735-1745. doi: 10.1056/NEJMoa2012883. Epub 2020 Aug 30. N Engl J Med. 2020. PMID: 32865374 Clinical Trial.
Introduction.
Saijo M. Saijo M. Vaccine. 2015 Nov 9;33(45):6027-8. doi: 10.1016/j.vaccine.2015.10.025. Epub 2015 Oct 21. Vaccine. 2015. PMID: 26475446
Prof. S. Hashizume developed a highly attenuated smallpox vaccine. The development of these vaccines has contributed not only to reduce the burden of infectious diseases in our society, but also to developing the new vaccines for other infectious diseases in the future. Th …
Prof. S. Hashizume developed a highly attenuated smallpox vaccine. The development of these vaccines has contributed not only to redu …
Ambient Particulate Air Pollution and Daily Mortality in 652 Cities.
Liu C, Chen R, Sera F, Vicedo-Cabrera AM, Guo Y, Tong S, Coelho MSZS, Saldiva PHN, Lavigne E, Matus P, Valdes Ortega N, Osorio Garcia S, Pascal M, Stafoggia M, Scortichini M, Hashizume M, Honda Y, Hurtado-Díaz M, Cruz J, Nunes B, Teixeira JP, Kim H, Tobias A, Íñiguez C, Forsberg B, Åström C, Ragettli MS, Guo YL, Chen BY, Bell ML, Wright CY, Scovronick N, Garland RM, Milojevic A, Kyselý J, Urban A, Orru H, Indermitte E, Jaakkola JJK, Ryti NRI, Katsouyanni K, Analitis A, Zanobetti A, Schwartz J, Chen J, Wu T, Cohen A, Gasparrini A, Kan H. Liu C, et al. N Engl J Med. 2019 Aug 22;381(8):705-715. doi: 10.1056/NEJMoa1817364. N Engl J Med. 2019. PMID: 31433918 Free PMC article.
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression.
Lama L, Adura C, Xie W, Tomita D, Kamei T, Kuryavyi V, Gogakos T, Steinberg JI, Miller M, Ramos-Espiritu L, Asano Y, Hashizume S, Aida J, Imaeda T, Okamoto R, Jennings AJ, Michino M, Kuroita T, Stamford A, Gao P, Meinke P, Glickman JF, Patel DJ, Tuschl T. Lama L, et al. Nat Commun. 2019 May 21;10(1):2261. doi: 10.1038/s41467-019-08620-4. Nat Commun. 2019. PMID: 31113940 Free PMC article.
Coarse Particulate Air Pollution and Daily Mortality: A Global Study in 205 Cities.
Liu C, Cai J, Chen R, Sera F, Guo Y, Tong S, Li S, Lavigne E, Correa PM, Ortega NV, Orru H, Maasikmets M, Jaakkola JJK, Ryti N, Breitner S, Schneider A, Katsouyanni K, Samoli E, Hashizume M, Honda Y, Ng CFS, Diaz MH, la Cruz Valencia C, Rao S, Palomares AD, Pereira da Silva S, Madureira J, Holobâc IH, Fratianni S, Scovronick N, Garland RM, Tobias A, Íñiguez C, Forsberg B, Åström C, Vicedo-Cabrera AM, Ragettli MS, Guo YL, Pan SC, Milojevic A, Bell ML, Zanobetti A, Schwartz J, Gasparrini A, Kan H. Liu C, et al. Am J Respir Crit Care Med. 2022 Oct 15;206(8):999-1007. doi: 10.1164/rccm.202111-2657OC. Am J Respir Crit Care Med. 2022. PMID: 35671471
Exposure-response relationship curves were pooled, and regional analyses were conducted. Measurements and Main Results: A 10 mug/m(3) increase in PM(2.5-10) concentration on lag 0-1 day was associated with increments of 0.51% (95% confidence interval [CI], 0.18%-0.84%), 0. …
Exposure-response relationship curves were pooled, and regional analyses were conducted. Measurements and Main Results: A 10 mug/m(3) …
316 results